Home > Animal Health & Nutrition > Veterinary Pharmaceuticals > Veterinary Renal Disease Market

Veterinary Renal Disease Market Share

Report ID: GMI8426
Published Date: Mar 2024
Report Format: PDF

Download Free Sample

Veterinary Renal Disease Market Share

The veterinary renal disease industry is characterized by the presence of several key players offering innovative solutions to healthcare providers. Leading companies in this market include Boehringer Ingelheim International GmbH, Zoetis Inc., and Elanco Animal Health Incorporated, among others. The strategic partnerships, mergers, and acquisitions are common strategies employed by players to expand their market presence, enhance their product portfolios, and gain a competitive advantage.

Veterinary Renal Disease Market Companies

Prominent players operating in the veterinary renal disease industry include:

Boehringer Ingelheim International GmbH
Dechra Pharmaceuticals
Elanco Animal Health Incorporated
General Mills Inc.
Hill's Pet Nutrition, Inc.
IDEXX Laboratories, Inc.
The J.M. Smucker Company
Mars Incorporated
Merck & Co., Inc.
Nestle Purina
Phibro Animal Health Corporation
Zoetis Inc.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Veterinary renal disease market size was USD 15.9 billion in 2023 and is expected to register 5.9% CAGR from 2024-2032 owing to the rise in pet ownership and advances in animal diagnostics worldwide.

The treatment segment held 67.3% share in 2023 and is expected to register an appreciable CAGR from 2024-2032 due to the growing prevalence of kidney disorders in animals, that increases the demand for effective treatment options.

North America veterinary renal disease industry reached USD 7 billion in 2023 and is expected to register a commendable CAGR from 2024-2032 due to the increasing emphasis on comprehensive animal healthcare in the region.

Dechra Pharmaceuticals, Elanco Animal Health Incorporated, General Mills Inc., Hill's Pet Nutrition, Inc., IDEXX Laboratories, Inc., The J.M. Smucker Company, Mars Incorporated, Merck & Co., Inc., and Nestle Purina, are some of the major veterinary renal disease companies worldwide.